Chemclin Diagnostics Balance Sheet Health
Financial Health criteria checks 5/6
Chemclin Diagnostics has a total shareholder equity of CN¥1.4B and total debt of CN¥223.6M, which brings its debt-to-equity ratio to 16.2%. Its total assets and total liabilities are CN¥1.8B and CN¥435.9M respectively. Chemclin Diagnostics's EBIT is CN¥150.9M making its interest coverage ratio -10.2. It has cash and short-term investments of CN¥878.3M.
Key information
16.2%
Debt to equity ratio
CN¥223.60m
Debt
Interest coverage ratio | -10.2x |
Cash | CN¥878.25m |
Equity | CN¥1.38b |
Total liabilities | CN¥435.93m |
Total assets | CN¥1.82b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 688468's short term assets (CN¥1.0B) exceed its short term liabilities (CN¥184.3M).
Long Term Liabilities: 688468's short term assets (CN¥1.0B) exceed its long term liabilities (CN¥251.7M).
Debt to Equity History and Analysis
Debt Level: 688468 has more cash than its total debt.
Reducing Debt: 688468's debt to equity ratio has increased from 0% to 16.2% over the past 5 years.
Debt Coverage: 688468's debt is well covered by operating cash flow (86.1%).
Interest Coverage: 688468 earns more interest than it pays, so coverage of interest payments is not a concern.